Sahsine Tolunay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sahsine Tolunay has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Mine Ozsen
Bursa Uludag University Faculty of Medicine
10 shared publications - Mustafa Sehsuvar Gokgoz
Department of Breast Surgery, Uludag University School of Medicine, Bursa, Turkey
9 shared publications - Adem Deligönül
Bursa Uludağ University, Faculty of Medicine, Department of Medical Oncology, Bursa, Türkiye
3 shared publications - Elif Erturk
Vocational School of Health Services, Bursa Uludağ University, Bursa, Turkiye
3 shared publications - Mevlut Ozgur Taskapilioglu
Bursa Uludag Universitesi
3 shared publications - Türkkan Evrensel
Department of Medical Oncology, School of Medicine, Bursa Uludag University, 16059 Bursa, Turkey
3 shared publications
Latest Publications
- Open Access
- 4 August 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (8)
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast
Background: Neuroendocrine neoplasms (NEN) originate in many body parts, with 70% reported from the gastrointestinal system, 25% from the lungs. NENs of the breast account for < 1% of all NENs. The primary breast NEN nomenclature was changed in the most recent World Health Organization classification in 2019. Since the pathological classification has changed several times, there are no definitive data on treatment management. Methods: In this study, patients followed up in our clinic were pathologically reevaluated according to the latest classification. Results: The clinical characteristics, treatments, recurrence, and survival status of 36 patients with early stage primary breast NEN were examined. A statistically significant difference was determined in respect of overall survival (OS) for the Eastern Cooperative Oncology Group Performance Score (ECOG PS), type of surgery, age ≥ 70 years, PR positivity, and tumor size. A low ECOG PS, younger age, breast-conserving surgery (BCS), and small tumor diameter were associated with better survival. A low ECOG PS, early stage, BCS, and fewer than 4 malignant lymph nodes were associated with better disease-free survival. All the patients in this study were at an early stage and were treated for typical breast cancer, although some patients diagnosed with neuroendocrine carcinoma (NEC) received cisplatin and etoposide treatment. Conclusions: In our study, the prognosis of breast NEN patients was better than the literature data. Maybe the prognosis of patients evaluated as breast NEN according to the new classification is better than the older classification groups.
- 4 August 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (8)
Open AccessPrimary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast
Background: Neuroendocrine neoplasms (NEN) originate in many body parts, with 70% reported from the gastrointestinal system, 25% from the lungs. NENs of the breast account for < 1% of all NENs. The primary breast NEN nomenclature was changed in the most recent World Health Organization classification in 2019. Since the pathological classification has changed several times, there are no definitive data on treatment management. Methods: In this study, patients followed up in our clinic were pathologically reevaluated according to the latest classification. Results: The clinical characteristics, treatments, recurrence, and survival status of 36 patients with early stage primary breast NEN were examined. A statistically significant difference was determined in respect of overall survival (OS) for the Eastern Cooperative Oncology Group Performance Score (ECOG PS), type of surgery, age ≥ 70 years, PR positivity, and tumor size. A low ECOG PS, younger age, breast-conserving surgery (BCS), and small tumor diameter were associated with better survival. A low ECOG PS, early stage, BCS, and fewer than 4 malignant lymph nodes were associated with better disease-free survival. All the patients in this study were at an early stage and were treated for typical breast cancer, although some patients diagnosed with neuroendocrine carcinoma (NEC) received cisplatin and etoposide treatment. Conclusions: In our study, the prognosis of breast NEN patients was better than the literature data. Maybe the prognosis of patients evaluated as breast NEN according to the new classification is better than the older classification groups.
- Open Access
- 22 October 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1
Correction: Value of miR-31 and mir-150-3p as diagnostic and prognostic biomarkers for breast cancer
- 22 October 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1
Open AccessCorrection: Value of miR-31 and mir-150-3p as diagnostic and prognostic biomarkers for breast cancer
- 1 October 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-9
Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer
Background The most prevalent malignancy among women is breast cancer (BC). MicroRNAs (miRNAs) play a role in the initiation and progression of BC by influencing breast cancer stem cells (BCSCs) but the diagnostic and prognostic roles of those miRNAs on BC patients are still unknown. It was aimed to investigate expression profiles, diagnostic and prognostic potentials of BCSC-related miRNAs in different subtypes (Luminal A and B, HER2 + and TNBC) of BC patients. Methods and Results Expression analysis of 15 BCSC-related miRNAs was performed in 50 breast tumor tissues and 20 adjacent non-tumor tissues obtained from BC patients using the qRT-PCR method. The expression levels of miR-31 and miR-150-3p were significantly upregulated in the tumor tissues compared to the adjacent non-tumor tissues (p < 0.05). miR-31 expression upregulated in the Luminal A and Luminal B group compared to non-tumor tissue (p < 0.05). miR-31 expression was determined to be significantly higher in the Luminal group (Luminal A and B) compared to the aggressive group (HER2 + and TNBC) (p < 0.05). According to the ROC analysis, the area under the curve (AUC) of miR-31 and miR-150-3p were 0.66 with a sensitivity of 68% and a specificity of 70%. A significant inverse correlation was observed between miR-31 expression with metastatic carcinoma status, in situ component, and Ki67 value in tumors, and high miR-150-3p expression was correlated with p63 expression (p < 0.05). Conclusion miR-31 and miR-150-3p have the potential to serve as biomarkers for guiding diagnosis, evaluating prognosis, and metastatic process in patients with BC.
- 1 October 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-9
Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer
Background The most prevalent malignancy among women is breast cancer (BC). MicroRNAs (miRNAs) play a role in the initiation and progression of BC by influencing breast cancer stem cells (BCSCs) but the diagnostic and prognostic roles of those miRNAs on BC patients are still unknown. It was aimed to investigate expression profiles, diagnostic and prognostic potentials of BCSC-related miRNAs in different subtypes (Luminal A and B, HER2 + and TNBC) of BC patients. Methods and Results Expression analysis of 15 BCSC-related miRNAs was performed in 50 breast tumor tissues and 20 adjacent non-tumor tissues obtained from BC patients using the qRT-PCR method. The expression levels of miR-31 and miR-150-3p were significantly upregulated in the tumor tissues compared to the adjacent non-tumor tissues (p < 0.05). miR-31 expression upregulated in the Luminal A and Luminal B group compared to non-tumor tissue (p < 0.05). miR-31 expression was determined to be significantly higher in the Luminal group (Luminal A and B) compared to the aggressive group (HER2 + and TNBC) (p < 0.05). According to the ROC analysis, the area under the curve (AUC) of miR-31 and miR-150-3p were 0.66 with a sensitivity of 68% and a specificity of 70%. A significant inverse correlation was observed between miR-31 expression with metastatic carcinoma status, in situ component, and Ki67 value in tumors, and high miR-150-3p expression was correlated with p63 expression (p < 0.05). Conclusion miR-31 and miR-150-3p have the potential to serve as biomarkers for guiding diagnosis, evaluating prognosis, and metastatic process in patients with BC.
- 20 June 2024
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (1) , 223-232
Differential diagnosis of primary mesenchymal neoplasms of the breast
Objective While the majority of breast neoplasms originate from epithelial cells, a rare part of them originate from mesenchymal breast tissue. This study aims to present the histomorphological and clinicoradiological features of our series of primary mesenchymal breast tumors and to discuss the features of these tumors in light of the literature. Materials and methods Cases diagnosed as primary mesenchymal breast tumor in breast resection materials evaluated in our center between 2010 and 2023 were included. Results Of the 26 tumors included, 57.7% were diagnosed as benign and 42.3% as malignant mesenchymal tumor. Cases diagnosed as benign mesenchymal tumor were hemangioma, lipoma, extra-abdominal fibromatosis, leiomyoma, angiofibroma, lipomatosis, benign fibrous histiocytoma and granular cell tumor. Histopathological study results were compatible with angiosarcoma in 5 (45.4%), undifferentiated sarcoma in 3 (27.3%), myxofibrosarcoma in 2 (18.2%) cases and rhabdomyosarcoma in 1 (9.1%) case. Conclusion Primary breast sarcomas are rarely seen compared to benign mesenchymal tumors and constitute less than 0.1% of all malignant breast tumors. When histomorphological findings suggestive of a mesenchymal tumor are observed in breast specimens, sufficient sampling should be performed to exclude a possible phyllodes tumor, and clinicoradiological findings should be examined to exclude the possibility of a metastasis.
- 20 June 2024
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (1) , 223-232
Differential diagnosis of primary mesenchymal neoplasms of the breast
Objective While the majority of breast neoplasms originate from epithelial cells, a rare part of them originate from mesenchymal breast tissue. This study aims to present the histomorphological and clinicoradiological features of our series of primary mesenchymal breast tumors and to discuss the features of these tumors in light of the literature. Materials and methods Cases diagnosed as primary mesenchymal breast tumor in breast resection materials evaluated in our center between 2010 and 2023 were included. Results Of the 26 tumors included, 57.7% were diagnosed as benign and 42.3% as malignant mesenchymal tumor. Cases diagnosed as benign mesenchymal tumor were hemangioma, lipoma, extra-abdominal fibromatosis, leiomyoma, angiofibroma, lipomatosis, benign fibrous histiocytoma and granular cell tumor. Histopathological study results were compatible with angiosarcoma in 5 (45.4%), undifferentiated sarcoma in 3 (27.3%), myxofibrosarcoma in 2 (18.2%) cases and rhabdomyosarcoma in 1 (9.1%) case. Conclusion Primary breast sarcomas are rarely seen compared to benign mesenchymal tumors and constitute less than 0.1% of all malignant breast tumors. When histomorphological findings suggestive of a mesenchymal tumor are observed in breast specimens, sufficient sampling should be performed to exclude a possible phyllodes tumor, and clinicoradiological findings should be examined to exclude the possibility of a metastasis.
- 1 April 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (2) , 110-116
Histopathological Features Predicting Neuroendocrine Morphology in Primary Breast Tumors: A Retrospective Analysis
Objective: Neuroendocrine neoplasms of primary breast tumors are rare compared to locations, such as the respiratory system and gastrointestinal system, where they are frequently observed. The diagnostic criteria for primary neuroendocrine tumors of the breast have been changed since first description. Morphological and immunohistochemical features helpful in their diagnosis, which vary due to the heterogeneous nature of these tumors, are highlighted in this retrospective study. The purpose was to determine specific histopathological features that can identify neuroendocrine morphology in primary breast tumors. Materials and Methods: Cases diagnosed with invasive breast carcinoma from resection materials in a single center between 2011 and 2022 and in which neuroendocrine markers were investigated were included. Demographic information, initial histopathological diagnosis, presence of tumor in another organ, tumor location, size and surgical details of the cases were obtained from the hospital database and pathology reports. The slides were re-evaluated in terms of tumor growth pattern, cribriformity, tubule formation, nuclear features, prominence of nucleoli, palisading and basal location of nuclei, presence of grooves, cytoplasmic features and evidence of cytoplasmic border. Results: The presence of basally located nuclei, absence of tubule formation, inconspicuous nucleoli, fine nuclear chromatin, granular cytoplasm and inconspicuous cytoplasmic borders were frequent findings in tumors with neuroendocrine features (p<0.05). These features may help differentiate primary breast tumors with neuroendocrine features from other breast carcinomas. Conclusion: The histopathological features that are different from the specific features seen in classical neuroendocrine tumors, the absence of specific clinical and radiological findings, the inability to study neuroendocrine markers in every laboratory and the need to prove that the breast tumor is not a metastasis all create diagnostic difficulties for primary breast neuroendocrine neoplasms. We believe that the results of this study may help diagnose and identify more specific histomorphological features that help determine neuroendocrine morphology in primary breast tumors.
- 1 April 2024
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 20 (2) , 110-116
Histopathological Features Predicting Neuroendocrine Morphology in Primary Breast Tumors: A Retrospective Analysis
Objective: Neuroendocrine neoplasms of primary breast tumors are rare compared to locations, such as the respiratory system and gastrointestinal system, where they are frequently observed. The diagnostic criteria for primary neuroendocrine tumors of the breast have been changed since first description. Morphological and immunohistochemical features helpful in their diagnosis, which vary due to the heterogeneous nature of these tumors, are highlighted in this retrospective study. The purpose was to determine specific histopathological features that can identify neuroendocrine morphology in primary breast tumors. Materials and Methods: Cases diagnosed with invasive breast carcinoma from resection materials in a single center between 2011 and 2022 and in which neuroendocrine markers were investigated were included. Demographic information, initial histopathological diagnosis, presence of tumor in another organ, tumor location, size and surgical details of the cases were obtained from the hospital database and pathology reports. The slides were re-evaluated in terms of tumor growth pattern, cribriformity, tubule formation, nuclear features, prominence of nucleoli, palisading and basal location of nuclei, presence of grooves, cytoplasmic features and evidence of cytoplasmic border. Results: The presence of basally located nuclei, absence of tubule formation, inconspicuous nucleoli, fine nuclear chromatin, granular cytoplasm and inconspicuous cytoplasmic borders were frequent findings in tumors with neuroendocrine features (p<0.05). These features may help differentiate primary breast tumors with neuroendocrine features from other breast carcinomas. Conclusion: The histopathological features that are different from the specific features seen in classical neuroendocrine tumors, the absence of specific clinical and radiological findings, the inability to study neuroendocrine markers in every laboratory and the need to prove that the breast tumor is not a metastasis all create diagnostic difficulties for primary breast neuroendocrine neoplasms. We believe that the results of this study may help diagnose and identify more specific histomorphological features that help determine neuroendocrine morphology in primary breast tumors.
- Open Access
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 343-348
Pineal Bölge Tümörleri: Tek Merkez Deneyimi
Yetişkinlerde tüm intrakraniyal tümörlerin %1'inden azını, pediatrik grupta ise %3-11'ini oluşturan pineal bölge tümörleri oldukça heterojen bir gruptur. Bölgenin tümör ve lezyonlarını genel bir başlık altında toplayarak dört gruba ayırmak mümkündür. Bunlar germ hücreleri tümörler, pineal parankimal tümörler ve glioma gibi komşu yapılardan kaynaklanan tümörler ve diğerleri şeklindedir. Çalışmamıza merkezimizde 2005-2020 yılları arasında opere edilmiş tüm pineal bölge tümörleri dahil edildi. Olguların demografik bilgileri, ön tanı, tümör çapı, klinik ve radyolojik bilgileri, sağkalım durumu, nüks varlığı ve son kontrol tarihleri hastane veritabanından ve patoloji raporlarından elde edildi. Çalışmaya dahil edilen olgulara ait hematoksilen eozin boyalı preparatlar ile mevcutsa immünohistokimyasal ve histokimyasal çalışma yapılan preparatlar histopatolojik tanı ve grade açısından yeniden değerlendirildi. Olguların histopatolojik değerlendirmesinde 6 (%22,2) olgu menengioma, 5 (%18,5) olgu pineoblastoma, 4 (%14,8) olgu pineositoma, 2 (%7,4) olgu pineal bölgenin papiller tümörü, 2 (%7,4) olgu orta derecede farklılaşma gösteren pineal parankimal tümör, 2 (%7,4) olgu glioblastoma, 2 (%7,4) olgu germ hücreli tümör (germinoma ve matür kistik teratoma), 1 (%3,7) olgu oligodenrioglioma, 1 (%3,7) olgu pilositik astrositoma, 1 (%3,7) olgu metastatik karsinoma ve 1 (%3,7) olgu gliozis ve hemosiderin pigment birikimi şeklinde tanı aldı. Pineal bölge çeşitli benign ve malign natürde tümörlerin gözlenebildiği özel bir lokalizasyondur. Histopatolojik değerlendirme yapılmadan önce mutlaka olgunun klinik, laboratuvar ve radyolojik verilerine hakim olunmalıdır. Mikroskobik değerlendirme bölgenin sahip olduğu geniş tanı yelpazesi göz önünde bulundurularak, yapılmalı ve gerekli durumlarda immünohistokimyasal ve histokimyasal çalışmalardan yardım alınmalıdır.
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 343-348
Open AccessPineal Bölge Tümörleri: Tek Merkez Deneyimi
Yetişkinlerde tüm intrakraniyal tümörlerin %1'inden azını, pediatrik grupta ise %3-11'ini oluşturan pineal bölge tümörleri oldukça heterojen bir gruptur. Bölgenin tümör ve lezyonlarını genel bir başlık altında toplayarak dört gruba ayırmak mümkündür. Bunlar germ hücreleri tümörler, pineal parankimal tümörler ve glioma gibi komşu yapılardan kaynaklanan tümörler ve diğerleri şeklindedir. Çalışmamıza merkezimizde 2005-2020 yılları arasında opere edilmiş tüm pineal bölge tümörleri dahil edildi. Olguların demografik bilgileri, ön tanı, tümör çapı, klinik ve radyolojik bilgileri, sağkalım durumu, nüks varlığı ve son kontrol tarihleri hastane veritabanından ve patoloji raporlarından elde edildi. Çalışmaya dahil edilen olgulara ait hematoksilen eozin boyalı preparatlar ile mevcutsa immünohistokimyasal ve histokimyasal çalışma yapılan preparatlar histopatolojik tanı ve grade açısından yeniden değerlendirildi. Olguların histopatolojik değerlendirmesinde 6 (%22,2) olgu menengioma, 5 (%18,5) olgu pineoblastoma, 4 (%14,8) olgu pineositoma, 2 (%7,4) olgu pineal bölgenin papiller tümörü, 2 (%7,4) olgu orta derecede farklılaşma gösteren pineal parankimal tümör, 2 (%7,4) olgu glioblastoma, 2 (%7,4) olgu germ hücreli tümör (germinoma ve matür kistik teratoma), 1 (%3,7) olgu oligodenrioglioma, 1 (%3,7) olgu pilositik astrositoma, 1 (%3,7) olgu metastatik karsinoma ve 1 (%3,7) olgu gliozis ve hemosiderin pigment birikimi şeklinde tanı aldı. Pineal bölge çeşitli benign ve malign natürde tümörlerin gözlenebildiği özel bir lokalizasyondur. Histopatolojik değerlendirme yapılmadan önce mutlaka olgunun klinik, laboratuvar ve radyolojik verilerine hakim olunmalıdır. Mikroskobik değerlendirme bölgenin sahip olduğu geniş tanı yelpazesi göz önünde bulundurularak, yapılmalı ve gerekli durumlarda immünohistokimyasal ve histokimyasal çalışmalardan yardım alınmalıdır.
- Open Access
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 325-329
Central Nervous System Infectious Diseases Mimicking Malignancies Clinoradiologically
Santral sinir sistemi (SSS) enfeksiyonları gelişen tanı ve tedavi yöntemlerine rağmen hala önemli bir morbidite ve mortalite nedenidir. Gözlenen şikayetlerin nonspesifik olması özellikle intrakranial tüberküloma ve beyin absesi başta olmak üzere çeşitli SSS enfeksiyon hastalığının klinikoradyolojik olarak malignitelerle karışabilmesine neden olmaktadır. Bu durum göz önünde bulundurularak çalışmamızda klinikoradyolojik olarak maligniteleri taklit eden SSS enfeksiyöz hastalıklarının klinikoradyolojik ve histomorfolojik özelliklerini olgularımız üzerinden paylaşarak bilimsel literatüre katkıda bulunmak amaçlanmıştır. Bu retrospektif çalışmada patoloji arşivi taranarak, 2010-2023 yılları arasında klinikoradyolojik bulgular doğrultusunda malignite ön tanısı ile opere edilen ancak histopatolojik değerlendirme sonucu santral sinir sisteminin enfeksiyon hastalıkları ile uyumlu tanı alan 19 olgu dahil edildi. Çalışmaya dahil edilen 19 olgunun 8’i kadın, 11’i erkekti. Olguların ortalama yaş değeri 51+15,68 iken yaş dağılımı 21 ile 72 arasında değişmekteydi. Klinikoradyolojik bulgular doğrultusunda 6 olguya glial tümör, 3 olguya tümöral lezyon, 3 olguya neoplaziye bağlı patolojik kırık, 2 olguya meningioma, 2 olguya metastaz, 2 olguya sinir kılıfı tümörü ve 1 olguya hipofiz adenomu ön tanısı ile eksizyon planlandı. Histomorfolojik değerlendirmede olguların %52,6’sında nekrotizan granülomatöz iltihap, %15,8’inde süpüratif inflamasyon ve %10,5’inde kist hidatik ile uyumlu bulgular saptandı. SSS enfeksiyonları farklı predispozan durumlarda farklı etkenlerin neden olduğu, doğru ve etkin tedavi edilmediği takdirde morbidite ve mortalite oranları yüksek hastalıklardır. Bu hastalıkların santral sinir sisteminin primer ve metastatik maligniteleri ile örtüşen şikayet, semptom ve radyolojik bulguya sahip olması doğru tanı koymayı zorlaştıran durumlardır. Olguyu değerlendirirken ihtimaller akılda bulundurulmalı ve olgu klinik öyküsü ile birlikte bir bütün halinde değerlendirilmelidir.
- 31 December 2023
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 49 (3) , 325-329
Open AccessCentral Nervous System Infectious Diseases Mimicking Malignancies Clinoradiologically
Santral sinir sistemi (SSS) enfeksiyonları gelişen tanı ve tedavi yöntemlerine rağmen hala önemli bir morbidite ve mortalite nedenidir. Gözlenen şikayetlerin nonspesifik olması özellikle intrakranial tüberküloma ve beyin absesi başta olmak üzere çeşitli SSS enfeksiyon hastalığının klinikoradyolojik olarak malignitelerle karışabilmesine neden olmaktadır. Bu durum göz önünde bulundurularak çalışmamızda klinikoradyolojik olarak maligniteleri taklit eden SSS enfeksiyöz hastalıklarının klinikoradyolojik ve histomorfolojik özelliklerini olgularımız üzerinden paylaşarak bilimsel literatüre katkıda bulunmak amaçlanmıştır. Bu retrospektif çalışmada patoloji arşivi taranarak, 2010-2023 yılları arasında klinikoradyolojik bulgular doğrultusunda malignite ön tanısı ile opere edilen ancak histopatolojik değerlendirme sonucu santral sinir sisteminin enfeksiyon hastalıkları ile uyumlu tanı alan 19 olgu dahil edildi. Çalışmaya dahil edilen 19 olgunun 8’i kadın, 11’i erkekti. Olguların ortalama yaş değeri 51+15,68 iken yaş dağılımı 21 ile 72 arasında değişmekteydi. Klinikoradyolojik bulgular doğrultusunda 6 olguya glial tümör, 3 olguya tümöral lezyon, 3 olguya neoplaziye bağlı patolojik kırık, 2 olguya meningioma, 2 olguya metastaz, 2 olguya sinir kılıfı tümörü ve 1 olguya hipofiz adenomu ön tanısı ile eksizyon planlandı. Histomorfolojik değerlendirmede olguların %52,6’sında nekrotizan granülomatöz iltihap, %15,8’inde süpüratif inflamasyon ve %10,5’inde kist hidatik ile uyumlu bulgular saptandı. SSS enfeksiyonları farklı predispozan durumlarda farklı etkenlerin neden olduğu, doğru ve etkin tedavi edilmediği takdirde morbidite ve mortalite oranları yüksek hastalıklardır. Bu hastalıkların santral sinir sisteminin primer ve metastatik maligniteleri ile örtüşen şikayet, semptom ve radyolojik bulguya sahip olması doğru tanı koymayı zorlaştıran durumlardır. Olguyu değerlendirirken ihtimaller akılda bulundurulmalı ve olgu klinik öyküsü ile birlikte bir bütün halinde değerlendirilmelidir.
- 3 July 2023
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 19 (3) , 235-252
A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey
Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2, which are strongly associated with BC, are included in these criteria. The aim of this study was to compare BC index cases with non-BC individuals in terms of genotype and diagnostic features to investigate the genotype/demographic information association. Mutational analyses for the BRCA1/BRCA2 genes was performed in 2475 individuals between 2013-2022 from collaborative centers across Turkey, of whom 1444 with BC were designated as index cases. Overall, mutations were identified in 17% (421/2475), while the percentage of mutation carriers in cases of BC was similar, 16.6% (239/1444). BRCA1/BRCA2 gene mutations were detected in 17.8% (131/737) of familial cases and 12% (78/549) of sporadic cases. Mutations in BRCA1 were found in 4.9%, whereas 12% were in BRCA2 (p<0.05). Meta-analyses were performed to compare these results with other studies of Mediterranean-region populations. Patients with BRCA2 mutations were significantly more common than those with BRCA1 mutations. In sporadic cases, there was a lower proportion with BRCA1/BRCA2 variants, as expected, and these results were consistent with the data of Mediterranean-region populations. However, the present study, because of the large sample size, revealed more robust findings than previous studies. These findings may be helpful in facilitating the clinical management of BC for both familial and non-familial cases.
- 3 July 2023
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 19 (3) , 235-252
A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey
Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2, which are strongly associated with BC, are included in these criteria. The aim of this study was to compare BC index cases with non-BC individuals in terms of genotype and diagnostic features to investigate the genotype/demographic information association. Mutational analyses for the BRCA1/BRCA2 genes was performed in 2475 individuals between 2013-2022 from collaborative centers across Turkey, of whom 1444 with BC were designated as index cases. Overall, mutations were identified in 17% (421/2475), while the percentage of mutation carriers in cases of BC was similar, 16.6% (239/1444). BRCA1/BRCA2 gene mutations were detected in 17.8% (131/737) of familial cases and 12% (78/549) of sporadic cases. Mutations in BRCA1 were found in 4.9%, whereas 12% were in BRCA2 (p<0.05). Meta-analyses were performed to compare these results with other studies of Mediterranean-region populations. Patients with BRCA2 mutations were significantly more common than those with BRCA1 mutations. In sporadic cases, there was a lower proportion with BRCA1/BRCA2 variants, as expected, and these results were consistent with the data of Mediterranean-region populations. However, the present study, because of the large sample size, revealed more robust findings than previous studies. These findings may be helpful in facilitating the clinical management of BC for both familial and non-familial cases.
- Open Access
- 3 May 2023
- Published by The European Research Journal in The European Research Journal
- Vol. 9 (3) , 529-535
Evaluation of hematopoietic- and neurologic-expressed sequence 1-like (HN1L) protein levels in tissue and plasma of breast cancer patients
Objectives: Breast cancer is the second leading cause of cancer deaths among women. Therefore, there is a need for new approaches that increase the success of treatment in breast cancer. Cancer stem cells (CSCs) are associated with treatment resistance and metastasis, which are important problems in cancer treatment including breast tumors. In this study, the Hematopoietic- and neurologic-expressed sequence 1-like (HN1L), also known as Jupiter microtubule associated homolog 2 (JPT2) protein levels which is involved in the self-renewal of CSCs were evaluated in common and rare breast tumor types. Methods: In this context, HN1L protein levels were measured from plasma of 17 patients and from tumor and normal tissues of 9 patients by enzyme linked immunosorbent assay method. Results: Mean HN1L levels were measured as 1.63 ± 0.88 ng/mL in plasma samples, 2.18 ± 0.75 ng/mL in tumor tissue samples and 2.71 ± 0.88 ng/mL in normal tissue samples. A significant difference was observed between mean HN1L levels in plasma and normal tissue (p < 0.05). Correlation of HN1L protein levels with clinicopathological characteristics were analyzed. Accordingly, HN1L levels were positively correlated with tumor size and invasion status (r=0.425; p < 0.05 and r=0.449; p < 0.05, respectively). Conclusions: We believe that the importance of HN1L in management of breast cancers will be demonstrated more thoroughly when further studies are conducted with increased number of patients.
- 3 May 2023
- Published by The European Research Journal in The European Research Journal
- Vol. 9 (3) , 529-535
Open AccessEvaluation of hematopoietic- and neurologic-expressed sequence 1-like (HN1L) protein levels in tissue and plasma of breast cancer patients
Objectives: Breast cancer is the second leading cause of cancer deaths among women. Therefore, there is a need for new approaches that increase the success of treatment in breast cancer. Cancer stem cells (CSCs) are associated with treatment resistance and metastasis, which are important problems in cancer treatment including breast tumors. In this study, the Hematopoietic- and neurologic-expressed sequence 1-like (HN1L), also known as Jupiter microtubule associated homolog 2 (JPT2) protein levels which is involved in the self-renewal of CSCs were evaluated in common and rare breast tumor types. Methods: In this context, HN1L protein levels were measured from plasma of 17 patients and from tumor and normal tissues of 9 patients by enzyme linked immunosorbent assay method. Results: Mean HN1L levels were measured as 1.63 ± 0.88 ng/mL in plasma samples, 2.18 ± 0.75 ng/mL in tumor tissue samples and 2.71 ± 0.88 ng/mL in normal tissue samples. A significant difference was observed between mean HN1L levels in plasma and normal tissue (p < 0.05). Correlation of HN1L protein levels with clinicopathological characteristics were analyzed. Accordingly, HN1L levels were positively correlated with tumor size and invasion status (r=0.425; p < 0.05 and r=0.449; p < 0.05, respectively). Conclusions: We believe that the importance of HN1L in management of breast cancers will be demonstrated more thoroughly when further studies are conducted with increased number of patients.
- 1 April 2022
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 48 (1) , 13-18
Ependimoma ve Anaplastik Ependimoma Olgularında Sağkalım Belirleyicileri
Son dönemde ependimomalarda tanımlanan moleküler özellikler prognostik bir faktör olarak önerilmektedir. Ancak dünya genelinde eşit dağılıma sahip olmayan ekonomik koşullar moleküler çalışmaların rutin olarak tüm merkezlerde değerlendirilmesine olanak sağlamamaktadır. Bu durum göz önünde bulundurularak çalışmamızda ependimoma ve anaplastik ependimoma olgularımızdaki klinikopatolojik ve immünohistokimyasal özelliklerin sağkalım üzerindeki etkisinin araştırılması amaçlanmıştır. Çalışmamıza merkezimizde 2010-2020 yılları arasında eksizyon materyallerinden yaş ve cinsiyet ayrımı yapılmaksızın ependimoma, anaplastik ependimoma tanısı alan 64 olgu dahil edildi. Olguların demografik bilgileri, tümör çapı, klinik ve radyolojik bilgileri, sağkalım durumu, nüks varlığı ve son kontrol tarihleri hastane veri tabanından ve patoloji raporlarından elde edildi. Çalışmaya dahil edilen olgulara ait hematoksilen eozin (H&E) boyalı ve immünohistokimyasal çalışma yapılan lamlar yeniden değerlendirildi. Yapılan istatistiksel analizde nükssüz sağkalımla lokalizasyon ve rezeksiyon durumu arasında istatistiksel olarak anlamlı bir farklılık bulundu (p=0,050
- 1 April 2022
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 48 (1) , 13-18
Ependimoma ve Anaplastik Ependimoma Olgularında Sağkalım Belirleyicileri
Son dönemde ependimomalarda tanımlanan moleküler özellikler prognostik bir faktör olarak önerilmektedir. Ancak dünya genelinde eşit dağılıma sahip olmayan ekonomik koşullar moleküler çalışmaların rutin olarak tüm merkezlerde değerlendirilmesine olanak sağlamamaktadır. Bu durum göz önünde bulundurularak çalışmamızda ependimoma ve anaplastik ependimoma olgularımızdaki klinikopatolojik ve immünohistokimyasal özelliklerin sağkalım üzerindeki etkisinin araştırılması amaçlanmıştır. Çalışmamıza merkezimizde 2010-2020 yılları arasında eksizyon materyallerinden yaş ve cinsiyet ayrımı yapılmaksızın ependimoma, anaplastik ependimoma tanısı alan 64 olgu dahil edildi. Olguların demografik bilgileri, tümör çapı, klinik ve radyolojik bilgileri, sağkalım durumu, nüks varlığı ve son kontrol tarihleri hastane veri tabanından ve patoloji raporlarından elde edildi. Çalışmaya dahil edilen olgulara ait hematoksilen eozin (H&E) boyalı ve immünohistokimyasal çalışma yapılan lamlar yeniden değerlendirildi. Yapılan istatistiksel analizde nükssüz sağkalımla lokalizasyon ve rezeksiyon durumu arasında istatistiksel olarak anlamlı bir farklılık bulundu (p=0,050